








Have you heard claims that GLP-1 medication, like Ozempic, can increase some people’s fertility?
Though it can be helpful for some there is not enough evidence to suggest GLP-1 receptor agonists are beneficial or safe for everyone.
This has been a collaboration with @PWHRCanada.
Sources
- How glucagon-like peptide 1 receptor agonists work | Endocrine COnnections | June 2021
- Glucagon-like peptide-1 receptor: mechanisms and advances in therapy | Signal Transduction and Targeted Therapy – Nature | September 2024
- A Systematic Review on GLP-1 Receptor Agonists in Reproductive Health: Integrating IVF Data, Ovarian Physiology and Molecular Mechanisms | International Journal of Molecular Sciences – MDPI | January 2026
- The effects of glucagon-like peptide-1 receptor agonists on fertility, contraception, and pregnancy: clinical perspectives | The European Journal of Contraception & Reproductive Health Care | December 2025
- Effect of GLP1 Agonists on Reproduction | The Journal of Clinical Endocrinology & Metabolism – Oxford Academic | July 2025
- GLP-1 Receptor Agonists in Reproductive Medicine: A Narrative Review and Investigational Pilot Survey of Patient Perspectives in Academic Reproductive Endocrinology | Reproductive Sciences – Springer Nature Link | June 2026
- Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence | Frontiers in Endocrinology | October 2023
- Glucagon-like peptide-1 receptor agonists during pregnancy and lactation | CMAJ | December 2024
- GLP-1 use during early pregnancy may not increase risk of major adverse outcomes | Harvard T.H. Chan | June 2026
- Continuing Glucagon-Like Peptide-1 Receptor Agonists Into the First Trimester of Pregnancy and Pregnancy Outcomes: A Target Trial Emulation Study Using Claims Information | Annals of Internal Medicine | June 2026
- Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services | BJM Open | April 2024
- Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review | Reproductive Biology and Endocrinology | January 2025
- PMOS and GLP-1s | ScienceUpFirst | October 2026
Share our original Bluesky Post!
View our original Instagram Post!
